Tocilizumab rationed – hospitals allowed only 10-25% of usual supply

Public hospitals will now be allocated only a quarter of their usual supplies of intravenous tocilizumab (Actemra) while private hospitals will be limited to 10% of usual supply, the TGA has announced. The regulator said it had been notified by manufacturer Roche that there was now a critical shortage of the immunosuppressive drug and immediate ...

Already a member?

Login to keep reading.

© 2021 the limbic